Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1

US Patent 8968740 · Granted Mar 3, 2015

Assignee

Inventors

View full patent text on Google Patents →